Literature DB >> 1522214

Purification and partial sequencing of the nuclear autoantigen RA33 shows that it is indistinguishable from the A2 protein of the heterogeneous nuclear ribonucleoprotein complex.

G Steiner1, K Hartmuth, K Skriner, I Maurer-Fogy, A Sinski, E Thalmann, W Hassfeld, A Barta, J S Smolen.   

Abstract

RA33 is a nuclear autoantigen with an apparent molecular mass of 33 kD. Autoantibodies against RA33 are found in about 30% of sera from RA patients, but only occasionally in sera from patients with other connective tissue diseases. To characterize RA33, the antigen was purified from HeLa cell nuclear extracts to more than 90% homogeneity by affinity chromatography on heparin-Sepharose and by chromatofocusing. Sequence analysis of five tryptic peptides revealed that their sequences matched corresponding sequences of the A2 protein of the heterogeneous nuclear ribonucleoprotein (hnRNP) complex. Furthermore, RA33 was shown to be present in the 40S hnRNP complex and to behave indistinguishably from A2 in binding to single stranded DNA. In summary, these data strongly indicate that RA33 and A2 are the same protein, and thus identify on a molecular level a new autoantigen.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1522214      PMCID: PMC329965          DOI: 10.1172/JCI115921

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  Recombinant hnRNP protein A1 and its N-terminal domain show preferential affinity for oligodeoxynucleotides homologous to intron/exon acceptor sites.

Authors:  M Buvoli; F Cobianchi; G Biamonti; S Riva
Journal:  Nucleic Acids Res       Date:  1990-11-25       Impact factor: 16.971

Review 2.  Rheumatoid arthritis. Pathophysiology and implications for therapy.

Authors:  E D Harris
Journal:  N Engl J Med       Date:  1990-05-03       Impact factor: 91.245

3.  Crosslinking of hnRNP proteins to pre-mRNA requires U1 and U2 snRNPs.

Authors:  S H Mayrand; T Pederson
Journal:  Nucleic Acids Res       Date:  1990-06-11       Impact factor: 16.971

4.  Isolation and in vitro assembly of nuclear ribonucleoprotein particles and purification of core particle proteins.

Authors:  S F Barnett; S J Northington; W M LeStourgeon
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

5.  Demonstration of a new antinuclear antibody (anti-RA33) that is highly specific for rheumatoid arthritis.

Authors:  W Hassfeld; G Steiner; K Hartmuth; G Kolarz; O Scherak; W Graninger; N Thumb; J S Smolen
Journal:  Arthritis Rheum       Date:  1989-12

6.  Structure of rodent helix-destabilizing protein revealed by cDNA cloning.

Authors:  F Cobianchi; D N SenGupta; B Z Zmudzka; S H Wilson
Journal:  J Biol Chem       Date:  1986-03-15       Impact factor: 5.157

7.  An inhibitor specific for the mouse T-cell associated serine proteinase 1 (TSP-1) inhibits the cytolytic potential of cytoplasmic granules but not of intact cytolytic T cells.

Authors:  M M Simon; M Prester; M D Kramer; U Fruth
Journal:  J Cell Biochem       Date:  1989-05       Impact factor: 4.429

8.  Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus.

Authors:  M R Lerner; J A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

Review 9.  Antinuclear antibodies (ANAs): diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity.

Authors:  E M Tan; E K Chan; K F Sullivan; R L Rubin
Journal:  Clin Immunol Immunopathol       Date:  1988-05

10.  Immunopurification of heterogeneous nuclear ribonucleoprotein particles reveals an assortment of RNA-binding proteins.

Authors:  S Piñol-Roma; Y D Choi; M J Matunis; G Dreyfuss
Journal:  Genes Dev       Date:  1988-02       Impact factor: 11.361

View more
  24 in total

1.  Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis.

Authors:  Altan Ercan; Jing Cui; Dereck E W Chatterton; Kevin D Deane; Melissa M Hazen; William Brintnell; Colin I O'Donnell; Lezlie A Derber; Michael E Weinblatt; Nancy A Shadick; David A Bell; Ewa Cairns; Daniel H Solomon; V Michael Holers; Pauline M Rudd; David M Lee
Journal:  Arthritis Rheum       Date:  2010-08

2.  Anti-A2/RA33 autoantibodies are directed to the RNA binding region of the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. Differential epitope recognition in rheumatoid arthritis, systemic lupus erythematosus, and mixed connective tissue disease.

Authors:  K Skriner; W H Sommergruber; V Tremmel; I Fischer; A Barta; J S Smolen; G Steiner
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

3.  The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies.

Authors:  M Sebbag; M Simon; C Vincent; C Masson-Bessière; E Girbal; J J Durieux; G Serre
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

4.  The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies," autoantibodies specific for rheumatoid arthritis.

Authors:  M Simon; E Girbal; M Sebbag; V Gomès-Daudrix; C Vincent; G Salama; G Serre
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

5.  Normal human epidermal keratinocytes express in vitro specific molecular forms of (pro)filaggrin recognized by rheumatoid arthritis-associated antifilaggrin autoantibodies.

Authors:  E Girbal-Neuhauser; M Montézin; F Croute; M Sebbag; M Simon; J J Durieux; G Serre
Journal:  Mol Med       Date:  1997-02       Impact factor: 6.354

Review 6.  Immune checkpoint inhibitor-induced inflammatory arthritis as a model of autoimmune arthritis.

Authors:  Laura C Cappelli; Mekha A Thomas; Clifton O Bingham; Ami A Shah; Erika Darrah
Journal:  Immunol Rev       Date:  2020-01-13       Impact factor: 12.988

7.  Serum samples of patients with rheumatoid arthritis contain a specific autoantibody to "denatured" aldolase A in the osteoblast-like cell line, MG-63.

Authors:  F Ukaji; I Kitajima; T Kubo; C Shimizu; T Nakajima; I Maruyama
Journal:  Ann Rheum Dis       Date:  1999-03       Impact factor: 19.103

8.  Detection and expression of a cDNA clone that encodes a polypeptide containing two inhibitory domains of human calpastatin and its recognition by rheumatoid arthritis sera.

Authors:  N Després; G Talbot; B Plouffe; G Boire; H A Ménard
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

Review 9.  Update on autoantibodies in rheumatoid arthritis.

Authors:  S Louis Bridges
Journal:  Curr Rheumatol Rep       Date:  2004-10       Impact factor: 4.592

Review 10.  cDNA phage display for the discovery of theranostic autoantibodies in rheumatoid arthritis.

Authors:  Patrick Vandormael; Patrick Verschueren; Liesbeth De Winter; Veerle Somers
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.